News
To honour this dedication, SKF is offering the opportunity to update their tattoos to match the refreshed brand identity. One of the first to embrace this offer is József Mézes, an SKF ...
Proactive cybersecurity solution designed to stop attacks before they occur "The development of Active Defense Collective marks a significant advancement in our ability to provide clients with ...
The Department of Consumer Affairs (DACO) requested information from supermarkets and car dealerships, including the prices of certain goods, as part of an “active surveillance” that the ...
The past week has been a wild ride for businesses and markets, starting with President Trump's announcement of sweeping tariffs and ending with an abrupt pause on most of them. About 12 hours ...
SAN FRANCISCO, April 29, 2025 /PRNewswire/ -- The global active pharmaceutical ingredients market size is projected to reach USD 359.45 billion by 2030, and it is expected to exhibit a CAGR of 5. ...
DJT,” he wrote on his social media platform Truth Social at 9:37 a.m. Less than four hours later, Trump announced a 90-day pause on nearly all his tariffs. Stocks soared on the news, closing up ...
An icon of a human eye and eyelashes with a diagonal line through it. A two-lined pause icon for stopping interactions. A opening quote mark. A closing quote mark. An icon of an arrow. An icon of ...
SHANGHAI, April 14, 2025 /PRNewswire/ -- Nullmax, an artificial intelligence company specializing in autonomous driving applications, announced its debut at the 2025 Shanghai International Automobile ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...
Hosted on MSN20d
"Apnea" Discover the Power of Your BreathExperiment to find your rhythm. Active Pause Moments: During your breaks between strength training sets or in moments of lower intensity in cardiovascular activities, instead of just standing ...
NMPA of China has also officially accepted the NDA for VELSIPITY ® for the treatment of patients with moderately to severely active UC in December 2024. VELSIPITY ® is an effective and convenient, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results